These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16522256)

  • 1. Understanding the "lucky few": the conundrum of HIV-exposed, seronegative individuals.
    Shacklett BL
    Curr HIV/AIDS Rep; 2006 Feb; 3(1):26-31. PubMed ID: 16522256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Elite controllers and the mechanisms behind spontaneous control of HIV].
    Shasha D
    Harefuah; 2013 Aug; 152(8):481-5, 498. PubMed ID: 24167935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How important is the 'quality' of the cytotoxic T lymphocyte (CTL) response in protection against HIV infection?
    Rowland-Jones SL; Pinheiro S; Kaul R; Hansasuta P; Gillespie G; Dong T; Plummer FA; Bwayo JB; Fidler S; Weber J; McMichael A; Appay V
    Immunol Lett; 2001 Nov; 79(1-2):15-20. PubMed ID: 11595285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stress-associated reductions of cytotoxic T lymphocytes and natural killer cells in asymptomatic HIV infection.
    Evans DL; Leserman J; Perkins DO; Stern RA; Murphy C; Tamul K; Liao D; van der Horst CM; Hall CD; Folds JD
    Am J Psychiatry; 1995 Apr; 152(4):543-50. PubMed ID: 7694902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic profile of highly exposed yet HIV type 1-seronegative men.
    Yang OO; Boscardin WJ; Matud J; Hausner MA; Hultin LE; Hultin PM; Shih R; Ferbas J; Siegal FP; Shodell M; Shearer GM; Grene E; Carrington M; O'Brien S; Price CB; Detels R; Jamieson BD; Giorgi JV
    AIDS Res Hum Retroviruses; 2002 Sep; 18(14):1051-65. PubMed ID: 12396457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of HIV-1 Pathogenesis in Viremic Nonprogressors Is Independent of Gag-Specific Cytotoxic T Lymphocyte Responses.
    Salgado M; Garcia-Minambres A; Dalmau J; Jiménez-Moyano E; Viciana P; Alejos B; Clotet B; Prado JG; Martinez-Picado J
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus type 1 (HIV-1)-seronegative injection drug users at risk for HIV exposure have antibodies to HLA class I antigens and T cells specific for HIV envelope.
    Beretta A; Weiss SH; Rappocciolo G; Mayur R; De Santis C; Quirinale J; Cosma A; Robbioni P; Shearer GM; Berzofsky JA
    J Infect Dis; 1996 Feb; 173(2):472-6. PubMed ID: 8568315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Not just sheer luck! Immune correlates of protection against HIV-1 infection.
    Piacentini L; Fenizia C; Naddeo V; Clerici M
    Vaccine; 2008 Jun; 26(24):3002-7. PubMed ID: 18180082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward an understanding of the correlates of protective immunity to HIV infection.
    Haynes BF; Pantaleo G; Fauci AS
    Science; 1996 Jan; 271(5247):324-8. PubMed ID: 8553066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the role of host genetic and T-cell factors in resistance to HIV transmission from studies of highly HIV-exposed Thais.
    McNicholl JM; Promadej N
    Immunol Res; 2004; 29(1-3):161-74. PubMed ID: 15181279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and immune determinants of immune activation in HIV-exposed seronegative individuals and their role in protection against HIV infection.
    Fenizia C; Rossignol JF; Clerici M; Biasin M
    Infect Genet Evol; 2018 Dec; 66():325-334. PubMed ID: 29258786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Factors involved in resistance to human immunodeficiency virus infection].
    Restrepo C; Rallón NI; Benito JM
    Med Clin (Barc); 2011 Nov; 137(13):600-4. PubMed ID: 21382628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host determinants in HIV infection and disease. Part 1: cellular and humoral immune responses.
    Hogan CM; Hammer SM
    Ann Intern Med; 2001 May; 134(9 Pt 1):761-76. PubMed ID: 11329234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to HIV-1 infection among highly exposed sex workers in Nairobi: what mediates protection and why does it develop?
    Plummer FA; Ball TB; Kimani J; Fowke KR
    Immunol Lett; 1999 Mar; 66(1-3):27-34. PubMed ID: 10203031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids.
    Pinto LA; Sullivan J; Berzofsky JA; Clerici M; Kessler HA; Landay AL; Shearer GM
    J Clin Invest; 1995 Aug; 96(2):867-76. PubMed ID: 7635981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate and adaptive mucosal immunity in protection against HIV infection.
    Bergmeier LA; Lehner T
    Adv Dent Res; 2006 Apr; 19(1):21-8. PubMed ID: 16672545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-specific cytotoxic T lymphocytes, HLA-A11, and chemokine-related factors may act synergistically to determine HIV resistance in CCR5 delta32-negative female sex workers in Chiang Rai, northern Thailand.
    Sriwanthana B; Hodge T; Mastro TD; Dezzutti CS; Bond K; Stephens HA; Kostrikis LG; Limpakarnjanarat K; Young NL; Qari SH; Lal RB; Chandanayingyong D; McNicholl JM
    AIDS Res Hum Retroviruses; 2001 May; 17(8):719-34. PubMed ID: 11429112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood.
    Clerici M; Levin JM; Kessler HA; Harris A; Berzofsky JA; Landay AL; Shearer GM
    JAMA; 1994 Jan; 271(1):42-6. PubMed ID: 8258885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1-specific cellular immune responses among HIV-1-resistant sex workers.
    Fowke KR; Kaul R; Rosenthal KL; Oyugi J; Kimani J; Rutherford WJ; Nagelkerke NJ; Ball TB; Bwayo JJ; Simonsen JN; Shearer GM; Plummer FA
    Immunol Cell Biol; 2000 Dec; 78(6):586-95. PubMed ID: 11114968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noncytolytic inhibition of X4 virus by bulk CD8(+) cells from human immunodeficiency virus type 1 (HIV-1)-infected persons and HIV-1-specific cytotoxic T lymphocytes is not mediated by beta-chemokines.
    Geiben-Lynn R; Kursar M; Brown NV; Kerr EL; Luster AD; Walker BD
    J Virol; 2001 Sep; 75(17):8306-16. PubMed ID: 11483776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.